Видео ютуба по тегу Avacta

AVACTA GROUP PLC - Phase 1b Faridoxorubicin (AVA6000) Salivary Gland Cancer Data Release
AVACTA GROUP PLC - Phase 1b Faridoxorubicin (AVA6000) Salivary Gland Cancer Data Release
AVACTA GROUP PLC - Investor Presentation
AVACTA GROUP PLC - Investor Presentation
AVACTA GROUP PLC - Interim Results
AVACTA GROUP PLC - Interim Results
Avacta Life Sciences Corporate Presentation
Avacta Life Sciences Corporate Presentation
Прорыв в лечении рака? Почему Avacta может изменить рынок онкологии
Прорыв в лечении рака? Почему Avacta может изменить рынок онкологии
Кристина Кофлин — генеральный директор Avacta Therapeutics, выпуск 97
Кристина Кофлин — генеральный директор Avacta Therapeutics, выпуск 97
Прорыв в лечении рака или опасная ставка? Как Avacta и искусственный интеллект меняют биотех
Прорыв в лечении рака или опасная ставка? Как Avacta и искусственный интеллект меняют биотех
Bitesize briefing – Avacta
Bitesize briefing – Avacta
An Introduction to Avacta Life Sciences and Affimers
An Introduction to Avacta Life Sciences and Affimers
Avacta (AIM:AVCT) The Science of Affimer Technology
Avacta (AIM:AVCT) The Science of Affimer Technology
AVACTA GROUP PLC - Preliminary Results
AVACTA GROUP PLC - Preliminary Results
ADVFN - Avacta Group CEO interview
ADVFN - Avacta Group CEO interview
Avacta Group Plc stock analysis - would ChatGPT buy or sell today? [April 2025]
Avacta Group Plc stock analysis - would ChatGPT buy or sell today? [April 2025]
Avacta Group stock analysis - would ChatGPT buy or sell today? [August 2025]
Avacta Group stock analysis - would ChatGPT buy or sell today? [August 2025]
Executive interview – Avacta Group
Executive interview – Avacta Group
Hey, ChatGPT would you buy or sell Avacta Group Plc stock today? [March 2025]
Hey, ChatGPT would you buy or sell Avacta Group Plc stock today? [March 2025]
Avacta Animal Health - How to submit a sample for testing
Avacta Animal Health - How to submit a sample for testing
Visualising Protein Aggregation in the Avacta Optim
Visualising Protein Aggregation in the Avacta Optim
2017 04 27 Avacta
2017 04 27 Avacta
Avacta Case Study
Avacta Case Study
Avacta Group heading into 'crucial year' for its cancer therapeutics programmes
Avacta Group heading into 'crucial year' for its cancer therapeutics programmes
Can Avacta’s Cancer Breakthrough Survive a Ruthless Biotech Market?
Can Avacta’s Cancer Breakthrough Survive a Ruthless Biotech Market?
Avacta - Interactive 3D (i3D) app for conference marketing
Avacta - Interactive 3D (i3D) app for conference marketing